Impact of a Swiss adverse drug event prevention collaborative

E-ISSN： 1365-2753|21|4|717-726

ISSN： 1356-1294

Source： JOURNAL OF EVALUATION IN CLINICAL PRACTICE (ELECTRONIC), Vol.21, Iss.4, 2015-08, pp. : 717-726

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advancing Medication Safety: Establishing a National Action Plan for Adverse Drug Event Prevention

Joint Commission Journal on Quality and Patient Safety, Vol. 41, Iss. 8, 2015-01 ,pp. : 351-360

Joint Commission Resources

Access to resources Recommend Favorite

Reducing Adverse Drug Events: Lessons from a Breakthrough Series Collaborative

By Leape Lucian L. Kabcenell Andrea I. Gandhi Tejal K. Carver Penny Nolan Thomas W. Berwick Donald M.

Joint Commission Journal on Quality and Patient Safety, Vol. 26, Iss. 6, 2000-06 ,pp. : 321-331

Joint Commission Resources

Access to resources Recommend Favorite

Medication Event Huddles: A Tool for Reducing Adverse Drug Events

By Morvay Shelly Lewe Dorcas Stewart Barbara Catt Charline McClead Jr Richard E. Brilli Richard J.

Joint Commission Journal on Quality and Patient Safety, Vol. 40, Iss. 1, 2014-01 ,pp. : 39-0

Joint Commission Resources

Access to resources Recommend Favorite

The Response to an Adverse Drug Event: Complying with Standard MM.6.20

Joint Commission: The Source, Vol. 6, Iss. 6, 2008-06 ,pp. : 4-10

Joint Commission Resources

Access to resources Recommend Favorite

Novel Data‐Mining Methodologies for Adverse Drug Event Discovery and Analysis

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 91, Iss. 6, 2012-06 ,pp. : 1010-1021

John Wiley & Sons Inc

Access to resources Recommend Favorite